Sector ratings ICON Public Limited Company

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/12/2025 GMT			5-day change	1st Jan Change
185.86 ^USD	+2.52%		-1.02%	-11.37%

12-09	ICON plc Releases Findings from Two Biotech Sector Survey	CI
12-02	Icon survey reveals increasing clinical trial startup delays	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ICON PUBLIC LIMITED COMPANY	13.84B		AA
LONZA GROUP AG	47.19B		AAA
IQVIA HOLDINGS INC.	37.14B		AAA
BEONE MEDICINES AG	35.27B		-
CELLTRION, INC.	27.89B		A
REVOLUTION MEDICINES, INC.	15.04B	-	B	-		-
MEDPACE HOLDINGS, INC.	15.33B		BBB
TEMPUS AI, INC.	13.5B	-	A	-		-
IONIS PHARMACEUTICALS, INC.	12.77B	-	A	-		-
ASCENDIS PHARMA A/S	12.01B	-	-	-		-
EUROFINS SCIENTIFIC SE	11.69B		AA
QIAGEN N.V.	9.88B		AAA
BIO-TECHNE CORPORATION	9.16B		A
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	9.15B		A
ABIVAX	9.24B	-	BBB	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	8.21B	-	-	-	-	-	-	-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
PHARMARON BEIJING CO., LTD.	6.89B		AA
KYMERA THERAPEUTICS, INC.	6.25B	-	BBB	-		-
PRAXIS PRECISION MEDICINES, INC.	6.46B	-	B	-		-
Average	15.76B		A
Weighted average by Cap.			A